Company Filing History:
3 out of 6 
1 out of 4 Years Active: 2004-2019
Title: Klaus Eschmann: Innovator in Pharmaceutical and Nutraceutical Innovations
Introduction: Klaus Eschmann is a notable inventor based in Kleinblittersdorf, Germany. With a total of four patents to his name, Eschmann has made significant contributions to the fields of pharmaceuticals and nutraceuticals. His innovative work focuses on compositions that are beneficial for health, integrating micronutrients and unique proteins.
Latest Patents: Klaus Eschmann's latest patents showcase his dedication to advancing health sciences. One such patent discloses a composition that comprises a combination of extract in an amount of at least about 10 µg/mg and selenium in an amount ranging from about 0.0001 µg/mg to about 2.0 µg/mg. This composition may also include zinc as an additional micronutrient, and it can be formulated as a pharmaceutical or nutraceutical product. Another patent pertains to the recombinant preparation of selected bromelain fractions, which details a method for expressing recombinant cysteine proteases found in Bromelain. This method has been found to be superior to traditional purification techniques.
Career Highlights: Over the course of his career, Klaus Eschmann has been associated with prominent companies in the pharmaceutical industry, including Ursapharm Arzneimittel GmbH and Ursapharm Arzneimittel GmbH & Co. KG. His work at these organizations has propelled innovations that support health and wellness through advanced formulations.
Collaborations: Throughout his career, Eschmann has collaborated with several eminent colleagues, including Rainer Maurer and Rolf Müller. These partnerships have likely enriched his innovative endeavors and contributed to the successful development of his patented compositions.
Conclusion: Klaus Eschmann stands out as a visionary inventor whose work in the pharmaceutical and nutraceutical sectors has the potential to impact health positively. With his recent patents emphasizing innovative formulations, he continues to be a significant figure in the evolving landscape of health sciences.